Clinical Trials Directory

Trials / Conditions / Recurrent Childhood Pineoblastoma

Recurrent Childhood Pineoblastoma

11 registered clinical trials studyying Recurrent Childhood Pineoblastoma.

StatusTrialSponsorPhase
TerminatedPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervou
NCT02255461
Pediatric Brain Tumor ConsortiumPhase 1
WithdrawnEfficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
NCT02194452
Sue O'DorisioN/A
TerminatedGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS T
NCT01088763
National Cancer Institute (NCI)Phase 1
CompletedVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spi
NCT01076530
National Cancer Institute (NCI)Phase 1
CompletedVorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Cent
NCT00994500
National Cancer Institute (NCI)Phase 1
CompletedABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
NCT00946335
National Cancer Institute (NCI)Phase 1
CompletedBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn
NCT00638898
City of Hope Medical CenterPhase 1
CompletedAZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
NCT00326664
National Cancer Institute (NCI)Phase 1
CompletedLenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
NCT00100880
National Cancer Institute (NCI)Phase 1
CompletedCilengitide in Treating Children With Refractory Primary Brain Tumors
NCT00063973
National Cancer Institute (NCI)Phase 1
CompletedTemozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
NCT00052780
National Cancer Institute (NCI)Phase 1